Stockholm, Sweden

Fredrik Aidehag

This inventor holds 12 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Life Technologies Corporation, Nuvoair Ab. Active years: 2012-2025.

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Munich, DE (2012 - 2016)
  • Stockholm, SE (2018 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Fredrik Aidehag: Innovator in Reagent Technology

Introduction

Fredrik Aidehag is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of reagent technology, holding a total of 12 patents. His work has had a considerable impact on various industries, particularly in the life sciences.

Latest Patents

Among his latest patents is a "Container for Providing Reagents," which showcases his innovative approach to improving reagent delivery systems. This invention is designed to enhance the efficiency and effectiveness of reagent usage in various applications.

Career Highlights

Fredrik has worked with prominent companies such as Life Technologies Corporation and Nuvoair AB. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in technology and science.

Collaborations

Fredrik has collaborated with talented individuals in his field, including Axel Unger and Todd A. Pelman. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies.

Conclusion

Fredrik Aidehag's contributions to reagent technology and his impressive portfolio of patents highlight his role as an influential inventor. His work continues to inspire innovation in the life sciences sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…